Liberum Capital Revenue and Competitors
Estimated Revenue & Valuation
- Liberum Capital's estimated annual revenue is currently $46M per year.
- Liberum Capital's estimated revenue per employee is $231,000
Employee Data
- Liberum Capital has 199 Employees.
- Liberum Capital grew their employee count by -5% last year.
Liberum Capital's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO | Reveal Email/Phone |
2 | CEO (US) | Reveal Email/Phone |
3 | CEO | Reveal Email/Phone |
4 | Head Trade Support Services | Reveal Email/Phone |
5 | Head Recruitment | Reveal Email/Phone |
6 | Head Client Solutions | Reveal Email/Phone |
7 | Head European Corporate Access | Reveal Email/Phone |
8 | Head Business Development - Liberum Wealth, London and Guernsey | Reveal Email/Phone |
9 | Head Research | Reveal Email/Phone |
10 | Head Compliance | Reveal Email/Phone |
Liberum Capital Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.8M | 14 | -71% | N/A | N/A |
#2 | $90M | 343 | 6% | N/A | N/A |
#3 | $5.7M | 34 | 10% | N/A | N/A |
#4 | $449.5M | 1529 | 5% | N/A | N/A |
#5 | $26.9M | 128 | 0% | N/A | N/A |
#6 | $7.9M | 47 | 9% | N/A | N/A |
#7 | $8.2M | 49 | 4% | N/A | N/A |
#8 | $81.6M | 311 | -1% | N/A | N/A |
#9 | $1.6M | 13 | 0% | N/A | N/A |
#10 | $135.2M | 515 | -16% | N/A | N/A |
What Is Liberum Capital?
Liberum was started in September 2007 to provide a different style of broking in an industry where clients and staff were treated poorly by other institutions.Clients wanted to work with those they could trust, who knew their needs and who worked through thick and thin. They didn’t want fair-weather friends.
keywords:N/A
N/A
Total Funding
199
Number of Employees
$46M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Liberum Capital News
Liberum Capital restated a buy rating and issued a GBX 160 ($2.04) price objective on shares of The Restaurant Group in a report on Monday...
THG (LON:THG Get Rating)'s stock had its buy rating reaffirmed by equities researchers at Liberum Capital in a research report issued to...
They currently have a GBX 1,380 ($17.95) target price on the biopharmaceutical company's stock. Liberum Capital's target price would suggest a...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $53.2M | 199 | -23% | N/A |
#2 | $54.7M | 199 | 9% | N/A |
#3 | $15M | 199 | -1% | N/A |
#4 | $49.7M | 199 | 23% | N/A |
#5 | $48.6M | 199 | -12% | $225M |